Defining time in therapeutic range for busy clinicians: frequency of dose changes is a good surrogate marker to identify patients with suboptimal anticoagulation with warfarin

Thrombosis research

Volumn 134, Issue 3, 2014, Pages 584-586

  Vijenthira, Abirami ^a   Le Gal, Gregoire ^a   Castellucci, Lana A ^a   Carrier, Marc ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Acenocoumarol; Venous thrombosis; Warfarin

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

ADOLESCENT; ADULT; AGED; BLOOD; BLOOD CLOTTING; CROSS-SECTIONAL STUDY; DOSE CALCULATION; DRUG EFFECTS; DRUG MONITORING; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PREDICTIVE VALUE; PROCEDURES; RETROSPECTIVE STUDY; TIME FACTOR; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; BLOOD COAGULATION; CROSS-SECTIONAL STUDIES; DRUG DOSAGE CALCULATIONS; DRUG MONITORING; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM; WARFARIN; YOUNG ADULT;

EID: 85027945823     PISSN: None     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2014.06.024     Document Type: Article

References (0)